HomeCERS • NASDAQ
add
Cerus Corp
Previous close
$1.91
Day range
$1.73 - $1.93
Year range
$1.21 - $3.08
Market cap
319.86M USD
Avg Volume
1.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 38.36M | 23.86% |
Operating expense | 29.25M | -6.94% |
Net income | -9.69M | 37.97% |
Net profit margin | -25.25 | 49.93% |
Earnings per share | -0.05 | 44.44% |
EBITDA | -7.35M | 45.61% |
Effective tax rate | -0.77% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 72.18M | -23.77% |
Total assets | 189.14M | -9.65% |
Total liabilities | 138.97M | -7.21% |
Total equity | 50.16M | — |
Shares outstanding | 184.89M | — |
Price to book | 7.07 | — |
Return on assets | -10.31% | — |
Return on capital | -13.29% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.69M | 37.97% |
Cash from operations | 1.96M | 123.05% |
Cash from investing | 1.45M | 187.85% |
Cash from financing | 5.56M | 169.82% |
Net change in cash | 8.88M | 211.38% |
Free cash flow | 1.47M | 124.53% |
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
631